Nektar Therapeutics
NKTR
#4576
Rank
โ‚ฌ1.78 B
Marketcap
62,39ย โ‚ฌ
Share price
-3.50%
Change (1 day)
419.05%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -โ‚ฌ99.4 Million

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ62.6 Million. In 2024 the company made an earning of -โ‚ฌ0.11 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ99.4 Million-3.48%
2024 -โ‚ฌ0.11 Billion-56.85%
2023 -โ‚ฌ0.24 Billion-24.31%
2022 -โ‚ฌ0.32 Billion-30.25%
2021 -โ‚ฌ0.46 Billion17.87%
2020 -โ‚ฌ0.39 Billion0.88%
2019 -โ‚ฌ0.39 Billion-164.46%
2018 โ‚ฌ0.58 B-810.61%
2017 -โ‚ฌ83.01 Million-37.06%
2016 -โ‚ฌ0.14 Billion89.22%
2015 -โ‚ฌ69.7 Million48.22%
2014 -โ‚ฌ47.03 Million-65.93%
2013 -โ‚ฌ0.14 Billion-6.81%
2012 -โ‚ฌ0.15 Billion28.95%
2011 -โ‚ฌ0.12 Billion258.8%
2010 -โ‚ฌ32.02 Million-63.94%
2009 -โ‚ฌ88.79 Million-392.45%
2008 โ‚ฌ30.35 M-211.74%
2007 -โ‚ฌ27.18 Million-79.57%
2006 -โ‚ฌ0.14 Billion-16.9%
2005 -โ‚ฌ0.17 Billion81.53%
2004 -โ‚ฌ88.17 Million54.19%
2003 -โ‚ฌ57.18 Million-33.87%
2002 -โ‚ฌ86.46 Million-9.6%
2001 -โ‚ฌ95.64 Million73.39%
2000 -โ‚ฌ55.16 Million108.9%
1999 -โ‚ฌ26.41 Million39.48%
1998 -โ‚ฌ18.94 Million60.02%
1997 -โ‚ฌ11.84 Million18.05%
1996 -โ‚ฌ10.03 Million31.82%
1995 -โ‚ฌ7.61 Million57.14%
1994 -โ‚ฌ4.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.98 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.23 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.12 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.24 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.94 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.30 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ0.87 M-100.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.35 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland